Predictions
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€64.20
15.03.15
15.03.15
€68.00
15.09.15
15.09.15
-17.70%
15.09.15
15.09.15
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€61.31
11.03.15
11.03.15
€67.00
22.07.15
22.07.15
3.33%
22.07.15
22.07.15
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Top 10 in its market
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€89.02
15.02.15
15.02.15
€130.00
07.12.15
07.12.15
8.86%
07.12.15
07.12.15
Could be worthwhile Investment >10% per year
Undervalued
High dividend yield expected
positive Cash Flow expected
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€85.69
05.02.15
05.02.15
€100.00
18.03.15
18.03.15
7.04%
18.03.15
18.03.15
Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
Johnson & Johnson
Start price
Target price
Perf. (%)
€86.15
28.11.14
28.11.14
€92.00
23.01.15
23.01.15
6.79%
23.01.15
23.01.15
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
Pfizer Inc.
Start price
Target price
Perf. (%)
€21.90
27.10.14
27.10.14
€25.62
12.12.14
12.12.14
11.39%
12.12.14
12.12.14
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€81.88
08.09.14
08.09.14
€95.00
28.01.15
28.01.15
12.25%
28.01.15
28.01.15
Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€52.50
27.04.14
27.04.14
€120.00
23.03.15
23.03.15
67.05%
23.03.15
23.03.15
Pfizer Inc.
Start price
Target price
Perf. (%)
€21.31
22.04.14
22.04.14
€28.46
22.09.14
22.09.14
6.63%
22.09.14
22.09.14
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€60.61
28.02.14
28.02.14
€120.50
19.10.15
19.10.15
50.76%
19.10.15
19.10.15
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€14.68
27.07.11
27.07.11
€18.00
26.01.12
26.01.12
25.99%
26.01.12
26.01.12
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€13.88
21.11.10
21.11.10
€22.50
23.05.11
23.05.11
4.14%
23.05.11
23.05.11
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€15.52
25.04.10
25.04.10
€22.29
25.10.10
25.10.10
-9.83%
25.10.10
25.10.10
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued